Breast Cancer with Brain Metastases

• CLINICAL_TRIALS trial_result · 2026-04-08
  Clinical Trial Update: Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases [Phase 2]

  Phase 2 trial evaluating cisplatin with or without veliparib in patients with recurrent or metastatic triple-negative or BRCA mutation-assoc…

• CLINICAL_TRIALS trial_result · 2026-03-20
  Clinical Trial Update: Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases [EARLY_Phase 1]

  This EARLY_PHASE1 trial evaluating ketoconazole before surgery in patients with recurrent glioma or breast cancer brain metastases was termi…

• CLINICAL_TRIALS trial_result · 2024-07-31
  Clinical Trial Update: Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer

  A clinical trial evaluated hypofractionated image-guided radiation therapy for patients with stage IV breast cancer. The study status is com…

• CLINICAL_TRIALS trial_result · 2024-06-26
  Clinical Trial Update: Efficacy of Pyrotinib Plus Capecitabine in HER2-positive MBC With Active Brain Metastases That Have Failed ADCs [Phase 2]

  A Phase 2 trial evaluating Pyrotinib plus Capecitabine for HER2-positive metastatic breast cancer with active brain metastases that have pro…

• CLINICAL_TRIALS trial_result · 2023-12-01
  Clinical Trial Update: Pyrotinib Combined With Capecitabine and Bevacizumab for Patients With HER2 Positive Breast Cancer and Brain Metastases [Phase 2]

  Phase 2 trial evaluating pyrotinib with capecitabine and bevacizumab for HER2-positive breast cancer with brain metastases; status currently…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2022-06-01
  Clinical Trial Update: ARX788 in HER2-positive Breast Cancer Patients With Brain Metastases [Phase 2]

  Phase 2 clinical trial update for ARX788 in HER2-positive metastatic breast cancer with brain metastases.

• CLINICAL_TRIALS trial_result · 2022-05-02
  Clinical Trial Update: Palbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in China [Phase 2]

  A multi-center Phase 2 trial in China evaluating palbociclib, trastuzumab, pyrotinib, and fulvestrant for ER/PR-positive, HER2-positive brea…

• CLINICAL_TRIALS trial_result · 2017-10-12
  Clinical Trial Update: Proteome-based Immunotherapy of Brain Metastases From Breast Cancer [Phase 2, Phase 3]

  ClinicalTrials.gov update on a Phase 2/Phase 3 proteome-based immunotherapy trial for brain metastases from breast cancer; the current trial…